Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin in BRCA1-Positive Metastatic Breast Cancer
NCT01611727Phase 2Completed
- Sponsor
- Pomeranian Medical University in Szczecin
- Start
- Jul 2007
- Primary completion
- Jan 2009
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in breast cancer, sponsored by Pomeranian Medical University in Szczecin. Started Jul 2007; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01611727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01611727.